Loading...
Market
How will CVS Health stock perform compared to S&P 500 in 2025?
3
Resolution / Starting Odds
Outperform • 25%
Match • 25%
Underperform • 25%
Significantly Underperform • 25%
Stock market data from NYSE and S&P 500 index performance reports
Story
CVS Health Adds Four New Board Members, Including Glenview's Larry Robbins
Nov 18, 2024, 12:29 PM
CVS Health Corp. has announced the addition of four new members to its board, including Larry Robbins, the founder of Glenview Capital Management. This move comes as part of an agreement with the activist firm, which has been pushing for changes within CVS. The new appointments will increase the board's size to 16 members. The agreement was reported by The Wall Street Journal and other sources. CVS stock rose 1.6% in pre-market trading, and Wells Fargo upgraded CVS to Overweight with a target price of $66.
View original story
Similar markets
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Outperforms Walgreens • 25%
Underperforms Walgreens • 25%
Outperforms Cigna • 25%
Underperforms Cigna • 25%
Higher • 25%
Lower • 25%
Unchanged (+/- 5%) • 25%
Other • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Outperforms S&P 500 • 25%
Performs on par with S&P 500 • 25%
Underperforms S&P 500 • 25%
Significant drop (>10%) • 25%
Outperforms S&P 500 • 25%
Matches S&P 500 • 25%
Underperforms S&P 500 • 25%
Significantly underperforms S&P 500 • 25%
Outperform by more than 5% • 25%
Perform within 5% of S&P 500 • 25%
Underperform by 1-5% • 25%
Underperform by more than 5% • 25%
Outperforms S&P 500 • 25%
Matches S&P 500 • 25%
Underperforms S&P 500 • 25%
Significantly underperforms • 25%